Infertility Evaluation: Ovulation, Sperm, Tubes, and Treatment Options
Related service: OB-GYN Services
Infertility evaluation should assess both partners and the steps required for pregnancy: ovulation, usable sperm, open fallopian tubes, a receptive uterine cavity, appropriately timed intercourse or insemination, and embryo implantation. Evaluation usually begins after 12 months of trying when the female partner is younger than 35, after six months at age 35 or older, and sooner with irregular cycles, known tubal or male-factor risk, endometriosis, recurrent pregnancy loss, or age over 40.
When to Begin Testing
Age affects both the chance of conception per cycle and miscarriage risk, so waiting rules are not identical for every patient. Evaluation should begin promptly when periods are absent or very irregular, prior pelvic infection or ectopic pregnancy suggests tubal disease, chemotherapy or ovarian surgery may have affected reserve, sexual dysfunction limits exposure, or semen concerns are known.
Secondary infertility deserves the same structured approach as difficulty conceiving a first pregnancy. Prior conception does not guarantee current ovulation, tubal function, sperm quality, or uterine anatomy. Review the duration and frequency of attempts, contraception history, pregnancies, losses, deliveries, surgeries, infections, and medications.
Ovulation and Cycle History
Regular predictable cycles often indicate ovulation, but history is not always conclusive. Ovulation predictor kits detect an LH surge; a properly timed serum progesterone can support recent ovulation; and ultrasound monitoring is used in selected treatment cycles. Basal body temperature confirms a change only after it occurs and can add stress without improving every evaluation.
Irregular ovulation may reflect PCOS, thyroid disease, elevated prolactin, hypothalamic suppression, perimenopause, or primary ovarian insufficiency. Treatment depends on the cause. A medication that induces ovulation is not a substitute for identifying thyroid disease, nutritional deficiency, excessive exercise, or ovarian failure.
Ovarian Reserve
AMH, antral follicle count, and early-cycle FSH with estradiol estimate the quantity of recruitable follicles and help predict response to stimulation. They do not directly measure egg quality, guarantee natural fertility, or prove that pregnancy is impossible. Age remains the strongest population-level predictor of egg quality.
Results should be interpreted together and in context of hormonal contraception, ovarian surgery, endometriosis, and laboratory variation. A low result may justify faster referral or different treatment planning. A reassuring result should not be used to postpone childbearing without acknowledging age-related change.
Semen Evaluation Is an Early Test
Male factors contribute to infertility commonly enough that semen analysis should occur early, not after months of testing only the female partner. The analysis evaluates volume, concentration, motility, morphology, and other features. Abnormal results are often repeated because illness, fever, abstinence interval, collection, medications, heat, and laboratory variation can affect one sample.
Marked abnormalities, sexual or ejaculatory problems, endocrine symptoms, testicular findings, or genetic risk may require urologic evaluation. Testosterone therapy can suppress sperm production and should be disclosed. Over-the-counter fertility supplements do not replace an evidence-based male evaluation.
Fallopian Tubes and the Uterine Cavity
A hysterosalpingogram or contrast ultrasound can assess whether tubes appear open and outline the uterine cavity. No test is perfect: temporary tubal spasm can mimic blockage, and an open tube is not necessarily normal in function. Prior chlamydia, pelvic inflammatory disease, endometriosis, ectopic pregnancy, or pelvic surgery increases concern.
Transvaginal ultrasound evaluates the uterus, endometrium, ovaries, fibroids, polyps, and adnexal disease. Saline-infusion sonography or hysteroscopy may better define the cavity when a polyp, submucosal fibroid, scar, or congenital anomaly is suspected.
Treatment Matches the Cause
Timed intercourse may be sufficient when testing is reassuring and duration is short. Letrozole is commonly used to induce ovulation in PCOS; clomiphene and gonadotropins have selected roles. Intrauterine insemination can help with certain unexplained, cervical, or mild male factors. Each approach carries different monitoring needs and multiple-pregnancy risk.
IVF is not the first treatment for every patient, but earlier reproductive-endocrinology referral may be appropriate with advanced reproductive age, very low reserve, bilateral tubal disease, severe male factor, genetic testing needs, or failed lower-intensity treatment. Donor eggs, donor sperm, gestational carrier care, adoption, and choosing not to pursue treatment are also valid pathways.
Preconception Health
Start folic acid before pregnancy, review immunizations, medications, nicotine, alcohol, cannabis, occupational exposures, chronic conditions, and genetic carrier screening. Optimize diabetes, blood pressure, thyroid disease, epilepsy, and mental health without abruptly stopping necessary medications.
Intercourse every one to two days during the fertile window is generally sufficient; rigid timing can worsen stress and sexual dysfunction. Fertility care should include emotional support and transparent discussion of cost, success rates, time, burden, and when a change in plan makes sense.
One normal test does not close the evaluation, and one abnormal result should not be interpreted in isolation. Results are combined into a probability-based plan. The plan should specify which finding is being treated, expected chance per cycle, monitoring, stopping rules, and the point at which specialist referral offers a better use of time.
Frequently Asked Questions
When should I see a doctor for infertility?
Usually after 12 months of trying if under 35, after six months at 35 or older, and sooner with irregular cycles, known risk factors, or age over 40.
Does a normal AMH mean I will conceive naturally?
No. AMH estimates ovarian response and follicle quantity; it does not directly measure egg quality, tubal function, sperm, or implantation.
Why is semen analysis done early?
Male factors are common, semen analysis is relatively noninvasive, and delaying it can lead to incomplete or inefficient treatment.
Can blocked tubes be seen on regular ultrasound?
Routine ultrasound usually cannot confirm tubal openness. HSG or contrast ultrasound is generally used, with laparoscopy reserved for selected situations.
Does infertility always require IVF?
No. Treatment may include timing, treating an endocrine condition, ovulation induction, surgery in selected cases, insemination, IVF, or referral based on findings.
The Bottom Line
Infertility care works best when evaluation is complete enough to explain the likely barriers to conception. Understanding ovulation, sperm health, tubal status, and treatment options supports a clearer path forward.
Schedule a Visit
Complete Healthcare offers individualized infertility evaluation covering ovulation, sperm, tubes, and treatment options for patients in Richland and the Tri-Cities. Call 509-392-6700 to schedule a fertility evaluation.
Complete Healthcare, Richland, WA
Richard Lorenzo, D.O.
Women’s Health and Wellness Care in Richland, WA
